Instil Bio (TIL) vs Veru (VERU)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Veru (VERU) has outperformed Instil Bio (TIL) over the past year, losing 45.1% versus a loss of 68.0%. Over five years, VERU leads with a -97.2% price change compared with -98.2% for TIL. Instil Bio is the larger company by market cap ($44.5 million vs $41.3 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | TIL | VERU |
|---|---|---|
| Share price | $6.56 | $2.42 |
| Market cap | $44.49M | $41.26M |
| 1-day change | -4.23% | -1.63% |
| YTD return | -40.36% | +13.08% |
| 1-year return | -68.05% | -45.12% |
| 5-year return | -98.17% | -97.18% |
| EPS (TTM) | $-4.43 | $-0.61 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $21.98 | $7.33 |
| 52-week low | $5.67 | $2.05 |
| Distance from 52-week high | -70.15% | -66.98% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +6.71% | +960.74% |
| Average volume | 12.54K | 242.06K |
| Shares outstanding | 6.78M | 17.05M |
| Employees | 17 | 20 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- VERU has outperformed TIL by 22.9 percentage points over the past year.
About Instil Bio
TIL stock →Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 17 employees
About Veru
VERU stock →Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS) in Florida and internationally. It provides FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections.
Health Care · Biotechnology: Pharmaceutical Preparations · 20 employees
TIL vs VERU FAQ
Which is bigger, Instil Bio or Veru?
Instil Bio (TIL) is larger, with a market capitalization of $44.49M compared with $41.26M for Veru (VERU).
Which stock has performed better over the past year, TIL or VERU?
VERU returned -45.12% over the past 12 months, compared with -68.05% for TIL (price return, excluding dividends). Past performance does not predict future results.
Are Instil Bio and Veru in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Biological Products (No Diagnostic Substances) for Instil Bio and Biotechnology: Pharmaceutical Preparations for Veru.